Motley Fool Money cover image

Tech in 2024: AI and Dividends

Motley Fool Money

00:00

Navigating the Pharmaceutical Landscape

This chapter explores the current earnings season, especially in REITs, while analyzing the pharmaceutical industry's challenges due to patent expirations. It highlights the differences between traditional drugs and biologics, detailing the complexities of biosimilars and their market implications. The discussion also covers strategies pharmaceutical companies employ to navigate patent laws and enhance drug delivery methods, all within the evolving landscape of drug pricing and competition.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app